NACI to say AstraZeneca vaccine OK for those over age 65: source


The National Advisory Committee on Immunization (NACI) is expected to change its stance on the AstraZeneca COVID-19 vaccine to now recommend its use for Canadians over the age of 65, a senior government source tells CTV News. The source added that there will be a news conference Tuesday morning to confirm the details of the change. Earlier this month, the NACI recommended that people over the age 65 should be prioritized for the Pfizer-BioNTech and Moderna vaccines instead of the AstraZeneca version because there was more evidence concerning their efficacy in older people. The NACI does not impose rules around vaccination. It only offers recommendations, which then allow provinces to tailor their own vaccination rollout plans to fit their needs. Health Canada has stressed that “there were no safety concerns in this age group in the clinical studies, nor in the large numbers of seniors who have been vaccinated to date in countries that have already authorized the AstraZeneca vaccine.”

Notifications - Subscriptions
Notify of
Oldest Most Voted
Inline Feedbacks
View all comments

Would love your thoughts, please comment.x